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Abstract
Background: The prevalence of hypertension and diabetes are expected to increase in sub-Saharan Africa over the
next decade. Some studies have documented that lifestyle factors and lack of awareness are directly influencing the
control of these diseases. Yet, few studies have attempted to understand the barriers to control of these conditions
in rural settings. The main objective of this study was to understand the challenges to hypertension and diabetes
care in rural Uganda.
Methods: We conducted semi-structured interviews with 24 patients with hypertension and/or diabetes, 11 health
care professionals (HCPs), and 12 community health workers (known as village health team members [VHTs]) in
Nakaseke District, Uganda. Data were coded using NVivo software and analyzed using a thematic approach.
Results: The results replicated several findings from other settings, and identified some previously undocumented
challenges including patients’ knowledge gaps regarding the preventable aspects of HTN and DM, patients’ mistrust
in the Ugandan health care system rather than in individual HCPs, and skepticism from both HCPs and patients
regarding a potential role for VHTs in HTN and DM management.
Conclusions: In order to improve hypertension and diabetes management in this setting, we recommend taking
actions to help patients to understand NCDs as preventable, for HCPs and patients to advocate together for health
system reform regarding medication accessibility, and for promoting education, screening, and monitoring activities
to be conducted on a community level in collaboration with village health team members.
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Introduction
Non-communicable disease (NCD) related deaths are
expected to increase globally [1]. One third of NCD
mortalities globally have been attributed to cardiovascu-
lar diseases (CVD) [2, 3]. About 80% of the CVD-related
deaths occur in low and middle-income (LMIC) coun-
tries, and more than half of these deaths are a result of
complications of hypertension (HTN) and diabetes
(DM) [3, 4]. In Sub-Saharan Africa (SSA) the burden of
disease is expected to double for both HTN and DM by
2025 and 2035 respectively [5, 6]. The increase in preva-
lence of DM is especially rapid in Uganda, where the
number of people with DM is predicted to increase by
166.9% between 2013 and 2035, outpacing most other
countries [5, 7].
Poor control of HTN and DM under the direct influ-
ence of lifestyle factors and lack of awareness in Uganda is
the major contributor to the increase in these conditions
[8–10]. A nationwide NCD risk factor survey conducted
in 2015 concluded that awareness is more problematic in
Uganda than earlier smaller studies suggest and that lack
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of awareness disproportionately affects rural compared to
urban communities [9, 11–13]. The survey found that
only 6.0% of patients with HTN in rural areas were aware
of their condition, as opposed to 12.1% of patients with
HTN in urban areas [14]. Another NCD risk factor survey
conducted in 2016 in selected peri-urban and rural areas
of Uganda found 95.6% of those identified to have DM in
rural areas were unaware of their condition while far fewer
(65.0%) were unaware of their health status in urban areas
[11]. Adding to this disparity and the challenge to man-
agement of these conditions, the 2018 Service Availability
and Readiness Assessment survey conducted in Uganda
found that availability of HTN and DM medications were
limited to health facilities located in urban areas [15].
While several studies have now described the chal-
lenges associated with HTN and DM care in urban areas
of Uganda, less is known about the hurdles in rural set-
tings [16]. Our study addresses this gap and aims to
understand the challenges to HTN and DM care in rural
Uganda using qualitative research methods. We collected
and analyzed interviews from three key stakeholders in
rural Nakaseke District: health care professionals (HCP),
community health workers (known locally as village
health team members [VHTs]), and patients with hyper-
tension and/or diabetes. We also make recommendations
based on the findings to improve HTN and DM care in
rural Uganda.
Methods
Semi-structured face-to-face in-depth interviews were
conducted with HCPs, VHTs, and patients in order to
identify challenges to HTN and DM care in rural Uganda
from the viewpoints of the three key stakeholder groups.
Setting
Nakaseke is a rural district in Central Uganda approxi-
mately 66 km north of Kampala with an estimated popu-
lation of 191,100 [17]. It consists of nine administrative
units or counties including Kasangombe, Nakaseke
sub-county, and Nakaseke Town Council. These three
counties were chosen to maximize geographic variability
in patient care resources. The patients and VHTs each
lived in one of these three sub-counties and the HCPs
were recruited from public and private hospitals in these
three counties.
Participants and sampling
Adult individuals with HTN and/or DM who were partici-
pants in the Nakaseke Community - Based Cohort for Non-
Communicable Diseases: Community Based Models of
Prevention, Care and Management for Non-Communicable
Diseases (NCD Study) [Mulago Hospital Research and Eth-
ics Committee (MREC) #1079] cohort study were recruited
to participate in thissub-study. The NCD Study was a
collaboration between investigators at Yale, Charité Berlin,
Johns Hopkins, and Makerere Universities, as well as AC-
CESS (African Community Center for Social Sustainability),
a local non-governmental organization (NGO) and includes
16,694 adults aged over 40 years living in Nakaseke District,
Uganda for at least two years prior to study initiation, who
have previously been evaluated for chronic respiratory dis-
ease, HTN, DM, and kidney disease. An initial list of
VHTs working in Nakeseke District was obtained from
ACCESS, and additional VHTs were found through
VHT interviewee referrals (snowball sampling). The
HCPs were recruited initially based on referrals from
the administration at Nakeseke Hospital (Ministry of
Health district hospital), and additional HCPs were re-
cruited using a snowball sampling approach as well.
To maximize variation among patients, we purposely
selected three axes of diversity using a theoretical
sampling method: gender, the chronic condition (HTN
and/or DM), and the participant’s county of residence
(Kasangombe, Nakaseke sub-County, or Nakaseke Town
Council). Gender was chosen as an axis based on the po-
tential for differences between men and women in their
health seeking behaviors. The patients’ chronic condition
determined their experience with the illness and with
the process of HTN and/or DM management. The last
axis was participant county of residence. Nakaseke Town
Council is the location of the Ministry of Health’s district
hospital, Nakaseke Hospital. Residents of Nakeseke
Town Council have higher income and better access to
resources with a greater number of shops and amenities
available. Nakaseke sub-county is the next closest county
to the Nakaseke Hospital, and Kasangombe is located
the farthest away. Residents of both Nakaseke sub-
county and Kasangombe, have lower incomes and lim-
ited access to amenities compared to Nakeseke Town
Council. The geographic variation in the availability of
resources and distance to Nakaseke Hospital may impact
participants’ experiences with access to health care. To
ensure geographic representation, an equal number of
patients were selected from each of the three counties
(Fig. 1 Flow chart of patient recruitment). For similar
reasons, VHTs were selected using their gender and
counties in which they served as the axes of diversity.
For HCPs, their position in the health system was used
as the major axis of diversity.
Participants with HTN and/or DM were eligible to
participate if they satisfied all the following require-
ments: a) age ≥ 18 years, b) lived in Nakaseke District for
at least two years, c) were capable of understanding
study procedures and providing informed consent, and
d) had received treatment for HTN and/or DM for at
least one full year at health care facilities in Nakaseke
(to be able to adequately speak to their experience).
HCPs were eligible to participate if they satisfied all of
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the following requirements: a) involvement in the care
and treatment of patients with HTN or DM, b) practiced
location within Nakaseke District, and c) employment as
an HCP in Nakaseke District for one year or more.
VHTs were eligible to participate if they satisfied all the
following requirements: a) active involvement in the care
and treatment of individuals in Nakaseke District and, b)
worked in Nakaseke District for one year or more. We
recruited a total of 24 patients with HTN and/or DM,
11 HCPs, and 12 VHTs.
Data collection
A trained research assistant contacted participants from
the NCD study by phone. Patient participants had given
their consent to be contacted for additional research. All
participants were asked screening questions to confirm
their eligibility for the interview, invited to participate,
and, if interested, scheduled for the interview. During
the research visit, which took place at the patient home-
steads or place of work (HCPs and VHTs), the research
assistant obtained verbal informed consent from the par-
ticipants because the study posed minimal risk of harm
to participants, and the research context did not require
written consents out of respect for cultural concerns
regarding signed consent documents. Interviews were
conducted in Luganda for patients and VHTs, and in
English for HCPs.
Semi-structured face-to-face in-depth interviews of 30
to 60min were conducted either by the first author, by
the research assistant or both together. The interview
guide consisted of open-ended questions with prompts
for probes (interview guides for patients and HCPs are
shown in Table 1). Questions were asked about the
process of diagnosis and treatment of hypertension and
diabetes, ways in which patients engaged in self-
management of hypertension and diabetes, barriers and
facilitators to hypertension and diabetes treatment, and
the current and possible roles of VHTs in hypertension
and diabetes management. All interviews were audio-
recorded with hand-written field notes. All participant
interviews and VHT interviews in Luganda were tran-
scribed and then translated into English by the research
assistant, who is fluent in both languages. The interviews
conducted in English were transcribed by either the first
author or research assistant.
Analysis
For analysis, we used both inductive and deductive ap-
proach to thematic analyses [18] where multiple experi-
ences and perspectives contribute to developing the
final research outcome. The first and second authors
(HC, NLH) collaborated to create the initial code book
for each group of stakeholders. Using the initial code
book, two coders (HC, NJ) coded 24 patient transcripts,
and two coders (HC, MR) coded 12 VHT transcripts
and 11 HCP transcripts using Microsoft Word. The first
author (HC) and the coders (NJ, MR) adopted line by
line coding to capture emerging themes using a mix of
descriptive and conceptual codes and refined the
codebooks through weekly discussions. Once the code-
book was finalized based on consensus, the same coders
Fig. 1 Flowchart of patient recruitment. TC = Town Council; SC = Sub-county
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coded the remaining patient, VHT, and HCP interviews.
Once all transcripts were coded and consensus reached
among coders, the first author (HC) compiled the por-
tions of coded texts and exported into QSR NVivo soft-
ware version 11. The first author (HC) reviewed the
quotes with themes and concepts on challenges to HTN
and DM care and drafted a preliminary analysis. The
Table 1 Semi-Structured Interview Guides for Patient and HCP
interviews*
Domain I. Introductory Question on HTN and DM and associated
care
Patient
1. Can you describe to me your typical day?
Probe:
How does HTN/DM play a role in your daily routine?
2. Can you tell me how and when you found out you have HTN/DM?
Probe:
What was that experience like for you?
Knowledge and Attitudes
3. If you had to explain to a family member what HTN/DM is, how
would you explain it?
Probe:
What do you think caused your HTN/DM?
Do you think HTN/DM is preventable? Why or why not?
Do you think HTN/DM is curable? Why or why not?
4. What have you done in the past and what are you currently doing
to manage HTN/DM?
Probe:
Can you tell me what medications or other remedies you are taking
or had taken?
Does diet play a role? If so how?
Does exercise play a role? If so how?
HCP
1. Can you describe what your role is in this healthcare facility?
2. What happens to a patient with HTN/DM who comes to this
facility? Can you walk me through that process?
Domain II. HTN and DM care support and care system
Patient
5. Who do you go for treatment when you feel sick?
Probe:
Do you go to traditional healers or other non-medical providers?
If yes, can you tell me more about it?
Who do you trust to give you advice or information about HTN/DM?
6. Do you feel comfortable sharing your diagnosis of HTN/DM with
your family members? Why or why not?
7. Would you feel comfortable sharing your diagnosis of HTN/DM
with your neighbors or community? Why or why not?
8. What resources are available in your community for learning about
HTN/DM?
HCP
3. How are HTN/DM diagnosed in this community?
4. How do people with HTN/DM manage and treat their disease in
this community?
5. Can you tell me about any specific guidelines followed by HCPs in
Nakaseke district for HTN/DM diagnosis and management?
6. What can patients with HTN/DM do to be actively involved in their
health management?
7. Tell me about any recommendations you give to your patients for
managing HTN/DM?
Probe:
What are the characteristics of patients that are more likely to listen
to your advice and recommendations?
8. Have there been efforts to improve the care of patients with HTN/
DM in this community and facility?
9. Tell me about any community-based programs or resources avail-
able to adults with HTN/DM and their caregivers/family members in
Nakaseke district?
Domain III. Barriers and Facilitators
Patient
9. Tell me about the difficult parts of HTN/DM treatment access and
drug adherence for adults with HTN and DM in Nakaseke.
Table 1 Semi-Structured Interview Guides for Patient and HCP
interviews* (Continued)
10. Tell me about the facilitators of HTN/DM treatment access and
drug adherence for adults with HTN and DM in Nakaseke.
11. How satisfied are you with the health care services you receive for
HTN and DM? Please describe.
HCP
10. Tell me about the barriers to HTN/DM treatment access and
adhrerence for adults with HTN/DM in Nakaseke?
Probe:
Tell me what challenges you face in diagnosing HTN/DM.
What barriers do you face in following these guidelines?
11. What common challenges do you face in educating patients
about their HTN and DM diagnosis and/or management?
Probe:
Are there common knowledge gaps, myths, or misconceptions that
patients have that contribute to this?
12. How does the use of traditional and/or complementary and
alternative medicine play a role in the lives of your patients with
HTN/DM?
Probe:
How does it play a role in their decision to seek healthcare in
general? And in their decision to seek care for HTN/DM?
Are there specific characteristics of patients who are more likely to
seek care from traditional healers or other non-medical providers?
13. Tell me about the facilitators of HTN/DM treatment access and
adherence for adults with HTN/DM in Nakaseke?
Domain IV. The goal is to help participants discuss the role of
VHTs.
Patient
12. Have you interacted with or received care from a VHT?
13. Do you believe VHTs are an important part of the health system?
14. Do you think that VHTs could play a role in helping you manage
your HTN and DM?
HCP
14. What is the role of VHTs in the management of patients with
HTN/DM?
Probe:
How do you perceive the quality of care delivered by VHTs?
Ending Questions
Patient
15. What do you wish you knew more about, related to HTN/DM?
16. How would you like to receive information about HTN/DM and
how to manage it?
HCP
15. How comfortable do you feel managing patients with HTN/DM?
Please describe.
Probe:
(If any answer other than comfortable) what would help you feel more
comfortable in managing patients with HTN/DM?
16. Can you think of any other HCPs with HTN/DM related training in
the community that would be useful for us to speak with?
*The guide used for VHT interviews are not included
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analysis was then refined through discussions with the
research team.
Ethical approval and consent
Ethical approval for this study was granted by the Yale
University Human Subjects Committee, Mulago Hospital
Research and Ethics Committee (MREC) and the Uganda
National Council of Science and Technology (Reference
numbers 2000021365; MREC 1079, SS 4283 respectively).
All participants provided verbal consent to participate in
the study and agreed to anonymized data from their inter-
views being published.
Results
The thematic analysis produced three major themes and
9 sub-themes from interviews with 24 patients with HTN
and/or DM, 11 HCPs, and 12 VHTs. Figure 2 provides an
overview of the relationship between the major themes
and the sub-themes (Fig. 2 Summary of major themes
and sub-themes). Table 2 provides demographic charac-
teristics of the 47 total participants. Tables 3, 4 and 5
summarize the major themes and additional participant
quotes related to challenges in HTN and DM care, iden-
tified from interviewing the three key stakeholder groups.
Participants’ quotes are contextualized by characteristics
such as the chronic condition (HTN and/or DM), gender,
the participant’s county of residence, and the participant
identification number.
Patient-reported challenges in HTN and DM care
Lack of knowledge of HTN and DM
Patient interviews revealed that patients conceptualized
the cause, preventability, treatment, and curability of
HTN and DM with limitations. These lay conceptualiza-
tions limited patients’ ability to adhere to medications
and obtain timely screening. Many participants correctly
identified HTN and DM as non-communicable diseases.
However, they believed that only communicable diseases
were preventable and, therefore, that NCDs were not.
“They are not communicable like HIV […] You can’t
prevent hypertension or diabetes.” (HTN and DM,
Female, Kasangombe, P4)
Some patients described pondering their symptoms for
more than a year and delaying hospital screening, only
deciding to go to the hospital when their symptoms
became severe and affected their daily lives, or after con-
sulting with members of their community. Many pa-
tients thought that the cause of HTN and DM was
stress, others identified genetics, and some reported a
belief that the diseases affected people at random. The
belief that stress influenced disease development led
some patients to choose relaxation or television watch-
ing as HTN and DM self-care. Most patients acknowl-
edged the role of diet and physical activity in HTN and
DM management, as informed by their HCPs, but often
drew on limited or incorrect information on the topic.
Some patients, for example, advocated for avoiding
sweet potatoes or soda when feeling weak and one pa-
tient reported having been taught what to avoid eating,
but never what to eat.
“You hear them speak of what shouldn’t be eaten but
we have not yet gotten a teaching about how to
conduct our lives.” (DM only, Female, Kasangombe,
P11)
Fig. 2 Summary of major themes and sub-themes
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Lay sources of HTN and DM information
Financial constraints and physical distance appeared to
be major barriers to accessing health care. Instead of
making hospital visits, many patients reported relying
on advice from lay sources (family, neighbors, and com-
munity) for managing their HTN and DM. The fact
that HTN and DM were not associated with any stigma
seemed to encourage communication and information
sharing about the diseases within the community.
“Yes, [I feel comfortable sharing with family
members and neighbors] because somebody might
advise and recommend you to a better medication
or to traditional medicines.” (HTN only, Female,
Nakaseke Sub-county, P15)
Most of the information on HTN and DM available to
study participants appeared to have been defined collect-
ively by the community, drawing upon experiences of
individual community members. As a result, many pa-
tients reportedly made decisions to receive triage after
their symptoms were legitimized by families and neigh-
bors. Patients also reported sometimes changing their
medication (type or dosage) based on community
Table 2 Characteristics of Patients, HCPs, and VHTs who participated in the study
Characteristic Patients (N = 24) HCPs (N = 11) VHTs (N = 12)
Age groupa
18–30 0 1 (9.1%) 0
31–40 0 3 (27.3%) 4 (33.3%)
41–50 5 (22.7%) 3 (27.3%) 3 (25.0%)
51–60 10 (45.5%) 4 (36.4%) 5 (41.7%)
61–70 3 (13.6%) 0 0
71–80 2 (9.1%) 0 0
81–90 2 (9.1%) 0 0
Sex
Female 20 (83.3%) 8 (72.7%) 6 (50.0%)
Male 4 (16.7%) 3 (27.3%) 6 (50.0%)
Education levelb
None 1 (4.2%) 0 0
Primary 12 (50.0%) 0 5 (41.7%)
Secondary 5 (20.8%) 2 (18.2%) 6 (50.0%)
Post-secondary (Not including certificate) 2 (8.3%) 9 (81.8%) 1 (8.3%)
Diagnosis N/A N/A
Hypertension only 11 (45.8%)
Diabetes only 4 (16.7%)
Hypertension and diabetes concurrently 9 (37.5%)
Village
Kasangombe 9 (37.5%) 1 (9.1%) 4 (33.3%)
Nakaseke sub county 8 (33.3%) 0 4 (33.3%)
Nakaseke town council 7 (29.2%) 10 (90.9%) 4 (33.3%)
HCP role N/A N/A
Nurse 4 (36.4%)
Doctor 3 (27.3%)
Pharmacist 2 (18.2%)
Nutritionist 1 (9.1%)
Private Pharmacist 1 (9.1%)
The percentages might not add up to 100% due to rounding
aMissing two participants from the group of patients
bMissing four participants from the group of patients
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members’ recommendations. While patients reported
trusting the information provided by health profes-
sionals, open access to lay sources meant they were
prone to re-interpret the details such as HTN and DM
etiology and curability based on the experiences or be-
liefs of others in the community.
Patient trust in HCPs vs lack of involvement in the medical
decision-making processes
Patient interviews revealed that when patients did
interact with the healthcare system they had a limited
role in the medical decision-making process. Very few
patients could name or describe the drugs they were
currently taking.
“Their [the prescribed drugs] names! They [the
doctors] just give me the drugs, I don’t know the
Table 3 Themes defining patient challenges in HTN and DM
care
Lack of knowledge of HTN and DM
They are not communicable like HIV […] You can’t prevent hypertension or
diabetes. (HTN and DM, Female, Kasangombe, P4)
I don’t know. No [I can’t even speculate the cause], because I
never used to take sugar, indeed I was so perplexed when I was
told that I am diabetic. I couldn’t understand […] I didn’t have any
pain, or anything that would prompt me to go to the hospital, I
was just there feeling nothing. (DM only, Male, Nakaseke sub-
county, P10)
If someone shares about HIV what about diabetes, I wouldn’t hide it even
from a woman because she cannot contract diabetes, diabetes is not
communicable. (DM only, Male, Nakaseke town council, P9)
Yes [diet has many roles in managing diabetes]. It helps because
there are times when I get blurred vision when I delay eating
food, and when you eat and take medication too it is well for you.
Food moves with the drugs it helps to transport blood. (DM only,
Male, Nakaseke town council, P9)
You might have palpitations and also get worried of children’s school fees,
then you find increased blood sugar level but you are on drugs. So the
doctor asks, “are you taking your medication?” “Yes doctor I do take,” “what
are you worried about” and you come to realize that there is something
distressing you. (HTN and DM, Female, Nakaseke sub-county, P6)
You hear them speak of what shouldn’t be eaten but we have not
yet gotten a teaching about how to conduct our lives. (DM only,
Female, Kasangombe, P11)
Lay sources of HTN and DM information
Yes, [I feel comfortable sharing with family members and neighbors]
because somebody might advise and recommend you to a better
medication or to traditional medicines. (HTN only, Female, Nakaseke Sub-
county, P15)
I hear food with starch should not be eaten like cassava. [I get this
information] from our colleagues. (DM only, Female, Kasangombe,
P11)
Why wouldn’t I share with them [friends and neighbors]? [I share with
them because] maybe they could give me some advice. (HTN only, Female,
Kasangombe, P23)
My friend [advises me on hypertension]. They [my friends] also have
hypertension. (HTN only, Female, Nakaseke town council, P12)
There is no problem [sharing with neighbors about the condition] because I
explain to many of my friends, and relatives who say that they get heat in
the body, sweating, thirst because I also get these symptoms. I tell them to
reduce on taking sugar, reduce on eating fatty foods. (DM only, Male,
Nakaseke sub-county, P10)
I feel comfortable. Because I want to help them be more aware of
hypertension. I try to tell them to avoid getting worried when they
get a similar problem because worrying precedes hypertension.
(HTN only, Female, Kasangombe, P20)
Patient trust in HCPs vs lack of involvement in the medical
decision-making processes
Their [the prescribed drugs] names! They [the doctors] just give me the
drugs, I don’t know the names. I am just given the drugs. (HTN and DM,
Female, Kasangombe, P4)
I know them [the drugs], they are dispensed to me. […]do I know
how to read your English [to name the drugs]? (HTN and DM,
Female, Nakaseke town council, P1)
I am not a doctor, unless I bring you the prescription book but I don’t
know the drugs. (HTN and DM, Female, Kasangombe, P5)
Sometimes we find that the drugs are finished, and we are told to
go and buy from places were the drugs are, at times you don’t
have money and you have to first work to make the money then
go and buy the drugs. (DM only, Female, Kasangombe, P11)
When I take it, I feel like throwing up, I feel disgusted in my heart. [when
this happens,] I first take some break. I take a break for about 2 days such
that these that I have taken descend down (DM only, Female,
Kasangombe, P11)
I buy [drugs], they are not there at the hospital that is the
Table 3 Themes defining patient challenges in HTN and DM
care (Continued)
problem. […] The government has not endeavored to know that
diabetes exists it the country and that it affects people, I thought
that I was the first to ever get this disease and I almost became
hopeless but I realized that we were about 680 patients […] but
there are those who die without ever going to the hospital. (DM
only, Male, Nakaseke sub-county, P10)
“We are in a good relationship with the doctors, because they comfort us
and teach us what we need to do to live.” (DM only, Male, Nakaseke sub-
county, P8)
“It is doctors [I trust to give information on HTN and DM]. We get
our blood sugar level measured […] and if it has increased then I
resume taking drugs. Sometimes I take drugs, sometimes I don’t,
so you take one tablet once a day for hypertension and for
diabetes one tablet in the morning and one in the evening.” (HTN
and DM, Female, Nakaseke town council, P3)
That [information on any diseases] comes from a doctor and nobody can
diagnose a disease it is only a doctor who can do that [provide
information]. (DM only, Male, Nakaseke sub-county, P8)
“Many times, the person to trust [on HTN and DM information] is
the one who also has the disease. The second is the health worker.
Not the traditional herbalists, but the real professional health
worker because they are well trained.” (HTN and DM, Female,
Nakaseke sub-county, P18)
Inability to access medication due to financial constraints
“I was told to started on drugs, and to regularly come to [the hospital to]
pick up the drugs. However sometimes I go there and the drugs are not
available. I also don’t have money. Then I keep quiet with nothing to do.”
(HTN only, Female, Nakaseke town council, P17)
The only problem is when there are no drugs in the hospital.
When the drugs are finished, it is you who has to look for them to
survive. (DM only, Male, Nakaseke sub-county, P9)
Problem is lack of money to buy capsules to take. Even to get the drugs
from Nakaseke is far and, boda boda [motorcycle] are also expensive.
When there are no free drugs in hospitals, all you get is Panadol. (HTN
only, Female, Nakaseke sub-county, P16)
You have to take your prescription. [It is easy to get drugs] If it is
available [in the hospital] but right now I need money to buy the
drugs. (HTN only, Female, Kasangombe, P23)
I had not encountered any [difficulties] yet because we have been getting
the government drugs and even when there are only a few, at least they
divide and everyone gets a little and we are informed to come back [to the
hospital] when that is finished. We get to pick more drugs if the stocks are
refilled. (HTN and DM, Female, Nakaseke sub-county, P7)
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names. I am just given the drugs.” (HTN and DM,
Female, Kasangombe, P4)
Many patients reported leaving medical decisions
completely up to doctors, increasing the medical know-
ledge gap. This left patients more prone to modifying
their treatment without understanding the consequence.
As an example, patients would often stop taking their
medication or alter its dosage in response to side-effects
before consulting with their doctors. Those who chan-
ged their medication dosage reportedly did so based on
their experience and physical reactions. Some patients
who expressed discomfort with the idea of modern
drugs also reported terminating medication usage.
Table 4 Themes defining HCP challenges in HTN and DM care
Negative reputation associated with HCPs
Some people fear our attitudes, they don’t want to come to the hospital.
(Female, Nurse at Nakaseke Hospital, HCP 1)
They [patients] can fear the health workers […] the way you
handle that patient can affect the patient to come back to the
hospital. […] If we are friendly with the patients it will be ok.
(Female, Nurse at Nakaseke Hospital, HCP 1)
When [patients] reach the hospital, we tell them “you have high levels”
then they get worried. […] [We tell the patients] Once a diabetic is always
a diabetic. So that worries also. It will take long to make one stabilize [to
manage their condition]. (Female, Nurse at Nakaseke Hospital, HCP 8)
Some [patients] say some staffs are harsh. Some say, if you’re
going to hospital, people might think they have HIV. So, most
people fear hospitals. […] When a patient has taken drugs for 1
year then starts taking herbals, herbals fail, it [symptoms of DM]
comes back, and someone [a HCP] could abuse her [the patient],
“why weren’t you on diabetic drugs? Now you’re coming back?”
such things. You shout at her. It doesn’t feel good. (Female,
Pharmacist at Nakaseke Hospital, HCP 5)
Patients’ herbal medication use and hospital as the last resort
People believe in herbal so much even they may not come [to the
hospital]. Person comes in too late and say that we’ve been using herbal.
[…] hospital is always the last solution. (Female, Nurse in Nakaseke
Hospital, HCP 3)
Sometimes even those patients can take [traditional medicine] and
sometimes they don’t come to the hospital. But at the end, they
end up coming back here because they have tried that traditional
herbs and it doesn’t work. (Female, Nurse at Nakaseke Hospital,
HCP 1)
Especially those [patients] ones in the village, they are not educated very
well. “I was thinking herbal drugs,” those are the stories they give us. […]
They come in with their conditions worse. (Female, Nurse at Nakaseke
Hospital, HCP 3)
Some [patients] don’t have enough drugs because at times they
come here [hospital] and drugs are out of stock, [which is] another
reason they feel that these herbals are better than tablets.
(Female, Doctor at Nakaseke Hospital, HCP 7)
Challenges related to patient education on HTN and DM
We’ve not done enough of the counseling, because we don’t have the time
[…] Diabetes and hypertension needs time [in counseling] because, you
need to talk about lifestyles. For both hypertension and diabetes, when we
talk about weight reduction, it needs a lot of skills, it needs a lot of
examples, needs a lot of talking. (Male, Doctor in Kasangombe, HCP 9)
If we have budget for some fuel and go to villages, you can health
educate these people, you talk about symptoms of hypertension
and diabetes, you can health educate the community. (Female,
Nurse at Nakaseke Hospital, HCP 1)
We do our best to convince them [the patients] and tell them the
complications [of medication non-adherence]. But it is a struggle to con-
vince them to take their hypertensive drugs. If I take the blood pressure,
[and I] say it is ok, they [patients] don’t take their drugs. (Female, Nurse at
Nakaseke Hospital, HCP 3)
They [patients] are good at forgetting. They easily forget so we
continue to health educate them. (Female, Nurse at Nakaseke
Hospital, HCP 2)
Table 5 Themes defining VHT roles in HTN and DM care
Limited scope of VHT responsibilities related to health care
We have not taken the role of managing the diseases [HTN and DM] yet,
so we refer anyone we discover to the hospital. (Male VHT, Nakaseke town
council, VHT 9)
I don’t diagnose such patients, but if I find them in their homes I
urge them to go to a health facility. I do follow up on them.
(Female VHT, Nakaseke town council, VHT 11)
We encourage that they [patients with DM] […] get tested to know their
blood sugar levels to ensure that they are well and that it doesn’t continue
rising. (Male VHT, Kasangombe, VHT 1)
[We take care of patients with HTN and DM by] Visiting them and
telling them to take their medication. And going back for review
to hospital on due day. (Female VHT, Kasangombe, VHT 2)
I have never been there personally to see how it is done [diagnosis of HTN
and DM] but we advise them to go to hospital when they have symptoms.
(Female VHT, Nakaseke sub-county, VHT 4)
We refer patients with DM straight to the hospital when we
identify them (Male VHT, Nakaseke sub-county, VHT 6)
We find these patients and refer them and even do follow up encouraging
them to take their medication. (Female VHT, Nakaseke town council, VHT
11)
Concerns about VHT role in HTN and DM care from the
perspectives of patients and HCPs
I personally don’t believe that they can do it [manage DM]. It [knowledge
on DM] is hard. (HTN and DM, Female, Nakaseke sub-county P7)
They [VHTs] don’t help us in any way, and they have no role in
this disease. I would request that it is the patients that should be
trained. […] Their importance is weak, it cannot benefit us in any
way. They [VHTs] could be beneficial to other patients such as
those with malaria but our disease is so complicated. (DM only,
Male, Nakaseke sub-county, P10)
They [VHTs] have roles in other diseases but not concerning diabetes and
hypertension. I do not fully certify them. I don’t think [VHTs can play a role
in HTN and DM] maybe malaria and child health. I doubt their abilities.
(HTN and DM, Female, Kasangombe, P21)
I don’t talk with VHTs. They used to treat malaria back then and I
have never seen them help patients with hypertension. They are
necessary to help children under 5 years old by dispensing
malarial drugs but they are not helpful to us the elderly. They do
not give out drugs for hypertension and diabetes. They are not
trained, they simply help people. The good thing is that we have
village clinics even if they [VHTs] are not available. (HTN only,
Female, Nakaseke sub-county, P16)
I don’t know their role, but I think HTN and DM are a bit complicated for
them. They can only handle the simple diseases like malaria, diarrhea. […]
they are trained for HIV but not HTN and DM. And because they have very
little knowledge about HTN and DM that most of those people in the
villages [with HTN and DM] do not even have relationship with village
health team members. They are always trained and given special courses
[in HIV], but I never heard any about DM and HTN. (Male, Pharmacist at
Nakaseke Hospital HCP6)
They [VHTs] do a lot of work in the villages, but for HTN and DM,
it is above their standard. […] They don’t know enough to
convince the patients with HTN and DM. What drug to get, what
to eat, and what to drink. (Female, Pharmacist at Nakaseke
Hospital, HCP 5)
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“I get drugs from the hospital so when I have them, I
take my drugs. However, I don’t take them daily. I take
breaks from them, but there are times when you go
back [to the hospital] and if it [the blood pressure]
increases, I am given the drugs.” (HTN and DM,
Female, Nakaseke-sub county, P6)
Despite patients’ limited involvement in medical pro-
cesses, it is important to note that patients did not
report dissatisfaction with or concern about the compe-
tence of their care. In fact, most patients expressed
having trust in their doctors for information and in
making medical decisions while they also expressed
having trust in lay sources and adherence to traditional
herbal medicine.
“We are in a good relationship with the doctors,
because they comfort us and teach us what we need to
do to live.” (DM only, Male, Nakaseke sub-county, P8)
Inability to access medication due to financial constraints
Somewhat contradicting their comments on voluntary
lack of adherence to medication regimens, patients did
uniformly identify drug adherence as the most import-
ant treatment for HTN and DM, though also reported
that limited access to medication was a major barrier.
Although the Ugandan health care system funds most
of the health services provided in public hospitals, the
hospitals and lower level health centers frequently ex-
perience drug shortages. Given these drug shortages at
the public pharmacies, patients often are required to
purchase medications from private pharmacies, though
this is often at a substantial cost. Thus, patients re-
ported financial hardship as an additional barrier to
accessing medications due to high costs. As a result,
some patients reported reducing their medication dos-
age or mixing their drugs with traditional herbal medi-
cine. Most patients reported a belief that HTN and DM
were curable with consistent adherence to modern
drugs. Thus, many patients reported ceasing medica-
tion usage once symptoms disappeared.
“I was told to start on drugs, and to regularly come to
[the hospital to] pick up the drugs. However sometimes
I go there and the drugs are not available. I also don’t
have money. Then I keep quiet with nothing to do.”
(HTN only, Female, Nakaseke town council, P17)
HCP-reported challenges in HTN and DM care
HCPs frustrations about HTN and DM management
largely centered around patients’ lack of adherence to
treatment. HCPs reported lack of adherence as result-
ing from difficulty educating patients or their use of
alternative herbal medicines in place of modern medi-
cations. They also expressed the belief that the negative
reputation of HCPs prevented patients from seeking
health care.
Negative reputation associated with HCPs
HCPs expressed a frustration with patients’ lack of
medication adherence and their subsequently worsen-
ing biomarkers and symptoms in follow-up visits. Some
HCPs reported that patients feared the healthcare staff
because of HCP’s negative attitudes toward patients
and their lack of adherence or inconsistency in utilizing
medical services.
“some people fear our attitudes; they don’t want to
come to the hospital.” (Female, Nurse at Nakaseke
Hospital, HCP1)
Some of the same HCPs reported that limited drug
availability at the hospital and patients’ financial con-
straints were additional reasons for patients’ failure to
follow-up.
Patients’ herbal medication use and hospital as the last resort
There were also thoughts from HCPs that patients may
not adhere to medications due to a cultural preference
for herbal medicine. According to HCPs, most patients
with HTN and DM initially draw on herbal medicine
and seek out hospital-based treatment as a last resort.
“people believe in herbal so much even they may not
come [to the hospital]. Person comes in too late and
say that we’ve been using herbal. […] hospital is
always the last solution.” (Female, Nurse at Nakaseke
Hospital, HCP3)
HCPs also expressed concern that patients would some-
times terminate, alter dosage, or take their prescribed
medication concurrently with herbal medicine to compen-
sate for missing doses. A few HCPs also expressed con-
cern that taking herbal and modern medicines together
might cause antagonistic or negative reactions.
Challenges related to patient education on HTN and DM
Interviews with HCPs revealed challenges in their efforts
to educate patients with HTN and DM. The reported
challenges included lack of resources (educational and
human) and time constraints. HCPs reported having no
resources, such as clinical or educational guidelines, to
use for HTN and DM education. A few HCPs also
acknowledged the difficulties of lifestyle education due to
existing patient habits, such as routine meat consumption
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and taking motorized transportation as opposed to exercis-
ing. Some HCPs also expressed that the lack of funds and
resources to perform community outreach was a barrier to
initiating community-based education opportunities.
Additionally, some HCPs reported difficulties in pro-
viding HTN and DM education while also serving
patients with acute and urgent medical conditions. Some
HCPs reported having a lack of staff members with spe-
cialized knowledge of HTN and DM. For example,
nurses (the only medical professionals running Nakaseke
Hospital’s DM clinic) expressed major concerns about
not having an HCP with higher-level training present for
professional medical assistance. Some HCPs also re-
ported not providing HTN and DM education because
of the time commitment required.
“we’ve not done enough of the counseling, because we
don’t have the time […] Diabetes and hypertension
needs time [in counseling] because, you need to talk
about lifestyles. For both hypertension and diabetes,
when we talk about weight reduction, it needs a lot of
skills, it needs a lot of examples, needs a lot of talking”
(Male, Doctor in Kasangombe, HCP9)
VHT role in HTN and DM care
Limited scope of VHT responsibilities related to health care
While interviews overall reported VHTs’ active role in
communicable disease prevention (exemplified by
HCPs indicating that VHTs were especially helpful
with regard to HIV management and family planning),
VHT interviews revealed their limited role in HTN
and DM management. All VHTs defined their current
role in HTN and DM as either non-existent or limited
to hospital referrals when patients approached them
with symptoms.
“We have not taken the role of managing the diseases
[HTN and DM] yet, so we refer anyone we discover to
the hospital.” (Male VHT, Nakaseke town council,
VHT9)
Concerns about a VHT role in HTN and DM care from the
perspectives of patients and HCPs
Both patients and HCPs expressed concern with
VHTs taking on roles related to HTN and DM man-
agement. Many patients and some HCPs doubted
VHT’s ability to understand HTN and DM, voicing
the belief that communicable disease prevention is
simpler to understand, and NCD prevention, in the
case of HTN and DM, too complex.
“I personally don’t believe that they can do it [manage
DM]. It [knowledge of DM] is hard.” (HTN and DM,
Female, Nakaseke sub-county, P7)
“I don’t know their role, but I think HTN and DM are
a bit complicated for them. They can only handle the
simple diseases like malaria, diarrhea. […] they are
trained for HIV but not HTN and DM. And because
they have very little knowledge about HTN and DM
that most of those people in the villages [with HTN
and DM] do not even have relationship with village
health team members. They are always trained and
given special courses [in HIV], but I never heard any
about DM and HTN.” (Male, Pharmacist at Nakaseke
Hospital, HCP6)
Some HCPs worried that VHT’s might lack motivation
to volunteer for additional responsibility related to NCD
prevention if VHTs were not compensated monetarily.
One HCP cited HIV management as a successful ex-
ample. She attributed the success of HIV management
to organizations that financially supported VHT training,
mobilization, and compensation. She expressed her con-
cern about giving VHTs any role in HTN and DM man-
agement when there are no such organizations dedicated
to HTN and DM in rural Uganda.
Discussion
Our study provides a closer look at the challenges to
HTN and DM care in rural Uganda from the perspective
of patients, HCPs, and VHTs. In particular, we found
challenges related to patients’ difficulties accessing care
and adhering to treatment: patients’ knowledge gaps
regarding the preventable aspects of HTN and DM,
patients receiving HTN and DM information from lay
sources, patients’ mistrust in the Ugandan health care
system rather than in individual HCPs, drug shortages
due to financial constraints, and patients’ use of herbal
medication. Additionally, HCPs report barriers to patient
education on HTN and DM, and skepticism was re-
ported from both HCPs and patients regarding a poten-
tial role for VHTs in HTN and DM management.
Patients’ limited understanding of the preventable as-
pects of HTN and DM influenced participants’ health be-
haviors. While patients with HTN and DM in Nakaseke
district correctly identified HTN and DM as NCDs, they
were not aware these conditions were preventable based
on their non-communicable nature. To our knowledge,
this specific assumption formulated by patients has not
been observed in previous studies, and therefore may be
unique to this region. Previous studies have, however, ob-
served similar patient behavior involving weaving together
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lay and expert explanations about the causes of illnesses
[19]. A study on chronic heart failure patients’ understand-
ing of their illness in Uganda attributed the misconstrued
understandings of illnesses mostly to the information lost
in translation between doctors and patients [19]. Such mis-
construed understandings or inaccurate patient beliefs
about the cause of illness are known to lead to late recogni-
tion of illness, late seeking of medical care, and changes to
where the care is sought [19, 20]. Our finding that patients
failed to understand the cause and preventability of HTN
and DM implies that there is a need for clear and compre-
hensive, health literacy-level appropriate health education
in Nakaseke and possibly other rural places in Uganda.
Another important finding was that individuals sought
information about their health conditions from untrained
community members, reporting little fear of stigma associ-
ated with revealing their conditions. Patients demonstrated
being open to sharing their experiences and knowledge
with other members of the community. This lack of stigma
is positive for future community-based health promotion
efforts. Prior studies in Uganda have also found that pa-
tients’ knowledge of NCD and choice of treatments were
influenced by community lay sources [19, 20]. Knowledge
of treatment options and efficacy has been found to lead
patients to seek care more readily [21]. A study found that,
with correct information, a community lay health worker
(CLHW)-led intervention was effective in promoting medi-
cation adherence and reinforcing basic disease education
among adults with HTN and/or DM in rural Mexico [22].
CLHWs led patients to promoted positive lifestyle change
and improved self-management due to informational and
psychosocial supports provided by CHWs [22]. Thus, simi-
lar types of interventions may able to produce similar
findings among patients with HTN and DM. Community-
based health promotion, engaging key community mem-
bers (such as CLHW or VHTs), may be a novel approach
to HTN and DM intervention in this setting.
In prior studies, inadequate communication between
providers and patients has frequently been associated
with patient dissatisfaction and mistrust of their pro-
viders [23, 24], which in turn have been major contrib-
utors to patient non-adherence to treatment [24].
While HCPs in this study suggested that similar issues,
particularly the patient perception of HCPs as having
negative attitudes, were driving the lack of patient
follow-up and medication adherence, it is striking that
none of the patient interviews indicated this negative
perception of HCPs. As such, patients and providers
had different perceptions of the challenges in HTN and
DM treatment adherence, which speaks to the current
level of communication between them. Patient inter-
views suggested that mistrust of the health care system,
rather than mistrust of the HCP personnel, drives
patients’ dissatisfaction and impedes their treatment
adherence. Based on this finding, joint advocacy efforts
by HCP and patients for system change in HTN and
DM care, particularly related to medication access, may
effectively improve care in rural Uganda.
Patients’ treatment adherence was particularly influ-
enced by drug shortages in rural Uganda. Drug shortages
seemed to be the most common reason for patients’ lack
of adherence, leading patients to adjust medication dos-
ages. Self-adjustment of medication is a commonly re-
ported coping response in situations where medications
are unavailable. For example, a recent study in urban
poor settings of South India observed that patients with
DM who lacked consistent access to medication altered
their prescribed dosage or schedule of intake without
seeking medical consultation [25]. The same study also
observed some patients compensating for the reduced
amount of medication dosage by taking herbal medicine
in combination [25].
The use of herbal medication was reported by HCPs
to be a major barrier to HTN and DM management.
They believed that it was more common for patients to
use herbal medication prior to initiating conventional
treatments. A study of HTN patients in rural Western
Kenya noted that patients took herbal medications in
addition to or instead of prescribed medications because
of their extensive advertisement, easy availability, and
low cost in comparison to conventional medical care
[26]. Future research in Uganda should focus on under-
standing factors associated with herbal medication use
and could explore herbal medicine providers as potential
partners in care and/or potential sources of referrals to
care for patients with HTN or DM.
HCPs also identified time constraints and lack of suf-
ficient healthcare personnel as challenges to educating
patients about HTN and DM. This finding of health
worker shortages is consistent with previous studies on
the state of the health workforce in sub-Saharan Africa
(SSA). A previous study reported the proportion of
trained doctors and nurses in the region who intend to
migrate ranged from 26 to 68% [27]. In an attempt to
tackle this issue, studies have explored task shifting
specifically in HTN and DM management in LMICs
[28, 29]. Task shifting strategies have been seen as a
low-cost and applicable action plan that utilizes exist-
ing resources such as lower-level health professionals
[29]. In our study, however, both patients and HCPs
expressed concerns about the ability of VHTs, who
would likely take on this role, to cope with prevention
and treatment of NCDs.
Much of the skepticism expressed by Nakaseke
patients and HCPs toward VHTs’ potential role in
HTN and DM care stemmed from their concern that
NCD knowledge is different than communicable dis-
ease and more difficult to learn. However, recent
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studies contradict this idea and have shown great po-
tential for VHTs to take part in NCD management
[30–32]. For example, a recent study in Eastern
Uganda observed that VHTs, despite feeling that they
were unprepared for a role in NCD management,
already had nuanced knowledge of NCDs and demon-
strated willingness be a part of the NCD health care
workforce [30]. Another study assessed the potential
for expansion of community health workers’ (CHW)
role in cardiovascular disease (CVD) management
across four LMICs (Bangladesh, Guatemala, Mexico,
and South Africa). The study found CHWs to be effi-
cient in screening and monitoring for CVD risk with
simplified screening instruments [32]. Furthermore,
promising work has been done by the Ministry of
Health NCD training program, involving improving
NCD knowledge in Ugandan health care workers [33].
While evidence strongly supports that VHTs can in-
deed be trained to provide HTN and DM education,
and we believe that this would be a successful strategy
in rural Uganda, additional funding for health finance
reform, and administrative support will likely be needed
to facilitate this change. Additionally, HCP and commu-
nity skepticism of the potential for VHT involvement in
HTN and DM prevention and care will need to be
addressed.
While our study contributed many new insights into
the challenges of HTN and DM in rural Uganda, there
are several limitations that must be noted. One potential
limitation is the gender imbalance in our study sample.
While we were able to select close to equal numbers of
participants on the axes based on disease and place of
residence (or work, for HCP), gender was significantly
skewed toward females for patients and HCPs. We ini-
tially planned to recruit patients equally by gender, how-
ever, more female patients were available and willing to
participate than males. Therefore, our findings may rep-
resent a limited scope of context that is more relevant to
the female patients. Despite the gender imbalance, the
HCP sample was actually representative of the care
provision in this setting. Secondly, interviewing the three
stakeholder groups separately may have not been helpful
in reaching consensus regarding the key problems in
managing HTN and DM in this setting. For example,
only HCPs mentioned fear as a major barrier preventing
patients from coming to the hospital. The same idea did
not emerge from patients but, rather, patients identified
financial constraints and difficulty in accessing facilities
as major reasons for their inability to make regular
follow-up visits to the hospital. That said, given the
power dynamics between the stakeholder groups, partic-
ipants may have felt less free to share their opinions if
they were in mixed groups. Third, as a small regional
study, the range of context relevance may be limited
and, thus, negatively impact the generalizability of our
conclusions. However, we tried to minimize this issue by
maximizing selection groups from using axes of diversity
on gender, disease, and place of residence. Finally, the
list used for initial VHT selection and recommendation
could have been biased toward more active VHTs and,
thus, the VHT perspectives may not have been reflective
of the broader VHT community.
Despite these limitations, our study highlights the
idea that there may be challenges to HTN and DM
care that are unique to rural Uganda. The perspec-
tives from three key stakeholders gives an overview of
the challenges faced by each group. In addition, a
major strength of our study is that it allowed us to
understand the locally grounded knowledge, attitudes,
and practices toward HTN and DM care from the
three key stakeholders. Our study findings can con-
tribute to create effective health service interventions
that could improve the quality of HTN and DM care
in Nakaseke, Uganda.
Conclusion
Using a qualitative approach, we illuminated the chal-
lenges that influenced patients’ compromised access to
care and lack of adherence to treatment in rural Uganda.
The three major challenges and the novel findings of our
study were the following: 1) patients’ knowledge gaps re-
garding the preventability of HTN and DM, 2) patients’
mistrust in the system of HTN and DM care rather than
in HCPs as individuals, and 3) skepticism from HCPs
and patients regarding VHTs’ ability to take roles in
HTN and DM management. Improving understanding
of the preventable aspects of NCDs and addressing sys-
temic issues associated with medication distribution to
health facilities are likely to lead to improvements in
HTN and DM management in this setting. We recom-
mend implementing a task shifting strategy that utilizes
VHTs to educate patients about prevention and cause of
non-communicable diseases and expands their existing
role to include screening and monitoring of HTN and
DM. Based on our findings, HTN and DM education
and screening activities conducted on a community level,
perhaps engaging community lay health workers, and joint
advocacy from HCPs and patients for reforming health
systems on medication distribution would be ideal.
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